top of page

Talking BTK degraders with the CEO of Nurix Therapeutics at #ASH23

Arthur Sands elaborates on two programs Nurix presented updated data for at ASH and dives into the company's pipeline and partnerships.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page